Accelerate Diagnostics, Inc. provided earnings guidance for the year 2022. For the quarter, the company expected to come in just below the low end of revenue guidance of $13 million to $14 million for the year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9353 USD | +6.09% | +0.46% | -76.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.14% | 20.26M | |
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-2.32% | 62.09B | |
+10.56% | 50.8B | |
+4.81% | 50.88B | |
-0.24% | 40.64B | |
+1.22% | 35.71B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. Provides Earnings Guidance for the Year 2022